332 related articles for article (PubMed ID: 20111769)
1. Artemisinin and its derivatives: a novel class of anti-malarial and anti-cancer agents.
Chaturvedi D; Goswami A; Saikia PP; Barua NC; Rao PG
Chem Soc Rev; 2010 Feb; 39(2):435-54. PubMed ID: 20111769
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of extraordinarily potent C-10 carba artemisinin dimers against P. falciparum malaria parasites and HL-60 cancer cells.
Chadwick J; Mercer AE; Park BK; Cosstick R; O'Neill PM
Bioorg Med Chem; 2009 Feb; 17(3):1325-38. PubMed ID: 19136263
[TBL] [Abstract][Full Text] [Related]
3. Orally active, antimalarial, anticancer, artemisinin-derived trioxane dimers with high stability and efficacy.
Posner GH; Paik IH; Sur S; McRiner AJ; Borstnik K; Xie S; Shapiro TA
J Med Chem; 2003 Mar; 46(6):1060-5. PubMed ID: 12620083
[TBL] [Abstract][Full Text] [Related]
4. Antimalarial and antitumor evaluation of novel C-10 non-acetal dimers of 10beta-(2-hydroxyethyl)deoxoartemisinin.
Jeyadevan JP; Bray PG; Chadwick J; Mercer AE; Byrne A; Ward SA; Park BK; Williams DP; Cosstick R; Davies J; Higson AP; Irving E; Posner GH; O'Neill PM
J Med Chem; 2004 Feb; 47(5):1290-8. PubMed ID: 14971909
[TBL] [Abstract][Full Text] [Related]
5. Antitumour and antimalarial activity of artemisinin-acridine hybrids.
Jones M; Mercer AE; Stocks PA; La Pensée LJ; Cosstick R; Park BK; Kennedy ME; Piantanida I; Ward SA; Davies J; Bray PG; Rawe SL; Baird J; Charidza T; Janneh O; O'Neill PM
Bioorg Med Chem Lett; 2009 Apr; 19(7):2033-7. PubMed ID: 19249201
[TBL] [Abstract][Full Text] [Related]
6. Anticancer and antimalarial efficacy and safety of artemisinin-derived trioxane dimers in rodents.
Posner GH; McRiner AJ; Paik IH; Sur S; Borstnik K; Xie S; Shapiro TA; Alagbala A; Foster B
J Med Chem; 2004 Feb; 47(5):1299-301. PubMed ID: 14971910
[TBL] [Abstract][Full Text] [Related]
7. Anticancer properties of artemisinin derivatives and their targeted delivery by transferrin conjugation.
Nakase I; Lai H; Singh NP; Sasaki T
Int J Pharm; 2008 Apr; 354(1-2):28-33. PubMed ID: 17942255
[TBL] [Abstract][Full Text] [Related]
8. Recent advances in artemisinin and its derivatives as antimalarial and antitumor agents.
Jung M; Lee K; Kim H; Park M
Curr Med Chem; 2004 May; 11(10):1265-84. PubMed ID: 15134519
[TBL] [Abstract][Full Text] [Related]
9. Antimalarial activities of (+)-deoxoartemisitene and its novel C-11, 13 derivatives.
Jung M; Lee K; Jung H; Kendrick H; Yardley V; Croft SL
Bioorg Med Chem Lett; 2004 Apr; 14(8):2001-3. PubMed ID: 15050646
[TBL] [Abstract][Full Text] [Related]
10. Artemisinin and Derivatives-Based Hybrid Compounds: Promising Therapeutics for the Treatment of Cancer and Malaria.
Peter S; Jama S; Alven S; Aderibigbe BA
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946603
[TBL] [Abstract][Full Text] [Related]
11. Antitumor activity of novel deoxoartemisinin monomers, dimers, and trimer.
Jung M; Lee S; Ham J; Lee K; Kim H; Kim SK
J Med Chem; 2003 Mar; 46(6):987-94. PubMed ID: 12620075
[TBL] [Abstract][Full Text] [Related]
12. New orally active derivatives of artemisinin with high efficacy against multidrug-resistant malaria in mice.
Singh C; Chaudhary S; Puri SK
J Med Chem; 2006 Nov; 49(24):7227-33. PubMed ID: 17125275
[TBL] [Abstract][Full Text] [Related]
13. Qinghaosu (artemisinin): chemistry and pharmacology.
Li Y
Acta Pharmacol Sin; 2012 Sep; 33(9):1141-6. PubMed ID: 22922345
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and evaluation of dihydroartemisinin and dihydroartemisitene acetal dimers showing anticancer and antiprotozoal activity.
Galal AM; Gul W; Slade D; Ross SA; Feng S; Hollingshead MG; Alley MC; Kaur G; ElSohly MA
Bioorg Med Chem; 2009 Jan; 17(2):741-51. PubMed ID: 19084416
[TBL] [Abstract][Full Text] [Related]
15. Malaria-infected mice are cured by oral administration of new artemisinin derivatives.
Posner GH; Chang W; Hess L; Woodard L; Sinishtaj S; Usera AR; Maio W; Rosenthal AS; Kalinda AS; D'Angelo JG; Petersen KS; Stohler R; Chollet J; Santo-Tomas J; Snyder C; Rottmann M; Wittlin S; Brun R; Shapiro TA
J Med Chem; 2008 Feb; 51(4):1035-42. PubMed ID: 18232653
[TBL] [Abstract][Full Text] [Related]
16. A mitochondria-targeting artemisinin derivative with sharply increased antitumor but depressed anti-yeast and anti-malaria activities.
Sun C; Cao Y; Zhu P; Zhou B
Sci Rep; 2017 Apr; 7():45665. PubMed ID: 28368011
[TBL] [Abstract][Full Text] [Related]
17. Biological Activities of Artemisinin Derivatives Beyond Malaria.
Liu X; Cao J; Huang G; Zhao Q; Shen J
Curr Top Med Chem; 2019; 19(3):205-222. PubMed ID: 30674260
[TBL] [Abstract][Full Text] [Related]
18. Synthetic chemistry fuels interdisciplinary approaches to the production of artemisinin.
Corsello MA; Garg NK
Nat Prod Rep; 2015 Mar; 32(3):359-66. PubMed ID: 25342519
[TBL] [Abstract][Full Text] [Related]
19. Heme as trigger and target for trioxane-containing antimalarial drugs.
Meunier B; Robert A
Acc Chem Res; 2010 Nov; 43(11):1444-51. PubMed ID: 20804120
[TBL] [Abstract][Full Text] [Related]
20. Artemisinin-derived dimers as potential anticancer agents: Current developments, action mechanisms, and structure-activity relationships.
Zhang B
Arch Pharm (Weinheim); 2020 Feb; 353(2):e1900240. PubMed ID: 31797422
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
